Cargando…
Potential drug targets of SARS-CoV-2: From genomics to therapeutics
The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) from China has become a global threat due to the continuous rise in cases of Coronavirus disease 2019 (COVID-19). The problem with COVID-19 therapeutics is due to complexity of the mechanism of the pathogenesis of this vir...
Autores principales: | Shamsi, Anas, Mohammad, Taj, Anwar, Saleha, Amani, Samreen, Khan, Mohd Shahnawaz, Husain, Fohad Mabood, Rehman, Md. Tabish, Islam, Asimul, Hassan, Md Imtaiyaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871800/ https://www.ncbi.nlm.nih.gov/pubmed/33577820 http://dx.doi.org/10.1016/j.ijbiomac.2021.02.071 |
Ejemplares similares
-
Unraveling Binding Mechanism of Alzheimer’s Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative Diseases
por: Shamsi, Anas, et al.
Publicado: (2019) -
Elucidating the Interaction of Human Ferritin with
Quercetin and Naringenin: Implication of Natural Products in Neurodegenerative
Diseases: Molecular Docking and Dynamics Simulation Insight
por: Shamsi, Anas, et al.
Publicado: (2021) -
Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy
por: Shamsi, Anas, et al.
Publicado: (2020) -
Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy
por: Mohammad, Taj, et al.
Publicado: (2020) -
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
por: Shamsi, Anas, et al.
Publicado: (2020)